---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-006239"
form_type: "8-K"
ticker: "OFIX"
cik: "0000884624"
company_name: "Orthofix Medical Inc."
filed_at: "2023-03-06T23:59:59+00:00"
generated_at: "2026-06-18T12:28:20.610278+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Orthofix reports Q4 2022 results; SeaSpine merger closed Jan 5; combined 2023 guidance $743-753M

## Summary
- Orthofix stand-alone Q4 net sales $122.2M (-2% reported, flat constant currency); net loss $7.1M vs $32.8M loss prior year.
- SeaSpine stand-alone Q4 net sales $63.4M (+14% YoY); net loss $19.0M vs $18.8M loss prior year.
- Combined company expects Q1 2023 net sales $166-170M and full-year 2023 net sales $743-753M.
- Merger of Orthofix and SeaSpine completed January 5, 2023; results do not include merger accounting adjustments.
- Orthofix borrowed $45M under credit facility in Jan/Mar 2023 to fund merger expenses and working capital.

## SEC filing metadata
- accession: 0000950170-23-006239
- form_type: 8-K
- ticker: OFIX
- cik: 0000884624
- company_name: Orthofix Medical Inc.
- filed_at: 2023-03-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/884624/000095017023006239/0000950170-23-006239-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/884624/000095017023006239/ofix-20230306.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-006239
- JSON: https://secwatch.observer/filing/0000950170-23-006239.json
- Plain text: https://secwatch.observer/filing/0000950170-23-006239.txt

## Key facts
- Earnings Releases
  Orthofix Medical Inc. reported financial results for fourth quarter and full year ended December 31, 2022.
  - Period: fourth quarter and full year ended December 31, 2022
  - Result: reported results
  source text: On March 6, 2023, Orthofix Medical Inc. (the “Company”) issued a news release announcing, among other things, its financial results for the fourth quarter and year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/884624/000095017023006239/0000950170-23-006239-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.